Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We recently discovered N‐hydroxy‐3‐[1‐(phenylthio)methyl‐1 H‐1,2,3‐triazol‐4‐yl]benzamide (NCC149) as a potent and selective histone deacetylase 8 (HDAC8) inhibitor from a 151‐member triazole compound library using a click chemistry approach. In this work, we present a series of NCC149 derivatives bearing various aromatic linkers that were designed and synthesized as HDAC8‐selective inhibitors. A series of in vitro assays were used to evaluate the newly synthesized compounds, four of which showed HDAC8 inhibitory activity similar to that of NCC149, and one of which displayed HDAC8 selectivity superior to that of NCC149. In addition, these top four compounds induced the increase of acetylated cohesin (an HDAC8 substrate) in HeLa cells in a dose‐dependent manner, indicating inhibition of HDAC8 in the cells. While none of these compounds enhanced the acetylation of H3K9 (a substrate of HDAC1 and 2), only one compound refrained from increasing α‐tubulin acetylation, a substrate of HDAC6, indicating that this compound is more selective for HDAC8 than the other derivatives. Furthermore, this HDAC8‐selective inhibitor suppressed the growth of T‐cell lymphoma cells more potently than did NCC149. These findings are useful for the further development of HDAC8‐selective inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two aromatic hydroxamate derivatives show high selectivity for human HDAC8 (hHDAC8)”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [17]
Citations
Cites
Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds
Miyaura, N., & Suzuki, A. (1995) · Chemical Reviews · doi:10.1021/cr00039a007 · Cited by 12,817
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Self-citationBalasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
Wilson, B. J., Tremblay, A. M., Deblois, G., Sylvain-Drolet, G., & Giguère, V. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0441 · Cited by 192
Suzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165
Self-citationWhitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., & Hiebert, S. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.607-619.2003 · Cited by 161
Lysine Demethylases Inhibitors
Suzuki, T., & Miyata, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201048w · Cited by 153
Self-citationSuzuki, T., Kasuya, Y., Itoh, Y., Ota, Y., Zhan, P., Asamitsu, K., Nakagawa, H., Okamoto, T., & Miyata, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068669 · Cited by 117
Self-citationZhang, X. M., Wharton, W., Yuan, Z., Tsai, S., Olashaw, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5106-5118.2004 · Cited by 104
Isoform-Selective Histone Deacetylase Inhibitors
Suzuki, T., Itoh, Y., & Miyata, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783885335 · Cited by 100
Self-citationDiscovery of histone deacetylase 8 selective inhibitors
Tang, W., Luo, T., Greenberg, E. F., Bradner, J. E., & Schreiber, S. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.134 · Cited by 98
Huang, W., Wang, Y., Chao, S.-W., Yang, C., Chen, L., Lin, M., Hou, W., Chen, M., Lee, T., Yang, P., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200300 · Cited by 85
An Unexpected Example of Protein‐Templated Click Chemistry
Suzuki, T., Ota, Y., Kasuya, Y., Mutsuga, M., KAWAMURA, Y., Tsumoto, H., Nakagawa, H., Finn, M. G., & Miyata, N. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002205 · Cited by 82
Self-citationEpigenetic Control Using Natural Products and Synthetic Molecules
Scior, T., & Garces-Eisele, S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361067 · Cited by 73
Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity
Karolczak-Bayatti, M., Sweeney, M., Cheng, J., Edey, L., Robson, S. C., Ulrich, S. M., Treumann, A., Taggart, M. J., & Europe-Finner, G. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278549 · Cited by 55
Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida, M., Shimazu, T., & Matsuyama, A. (2003) · PubMed · Cited by 49
Small-molecular modulators of cancer-associated epigenetic mechanisms
Itoh, Y., Suzuki, T., & Miyata, N. (2013) · Molecular BioSystems · doi:10.1039/c3mb25410k · Cited by 44
Self-citationAn Unexpected Example of Protein‐Templated Click Chemistry
Suzuki, T., Ota, Y., Kasuya, Y., Mutsuga, M., KAWAMURA, Y., Tsumoto, H., Nakagawa, H., Finn, M. G., & Miyata, N. (2010) · Angewandte Chemie · doi:10.1002/ange.201002205 · Cited by 14
Self-citation
Research works printed but not linked: 1
- Yoshida M., 2003, Prog. Cell Cycle Res., 5, 269
Cited by
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Inhibitors of histone deacetylase as antitumor agents: A critical review
Manal, M., Chandrasekar, M. J. N., Gomathi Priya, J., & Nanjan, M. J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.005 · Cited by 216
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
Wang, X., Huang, B., Liu, X., & Zhan, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.004 · Cited by 190
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 155
Metadata
- Authors
- Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., & Miyata, N.
- Affiliations
- Nagoya City University (JP)
- Institute for Quantitative Biosciences, The University of Tokyo (JP)
- Kyoto Prefectural University of Medicine (JP)
- Corresponding author
- Suzuki, Takayoshi
- Miyata, Naoki
- ORCID
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2014-01-08
- Volume
- 9
- Issue
- 3
- Pages
- 657-664
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W2148310814
- Cited by
- 71
- References
- 26
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24659050, 24689007)
- Precursory Research for Embryonic Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- HDAC8 inhibitors, HDAC8, triazole derivatives, aromatic linkers, H3K9 acetylation, alpha-tubulin acetylation, T-cell lymphoma, enzyme selectivity
- MeSH terms
- Antineoplastic Agents, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, HeLa Cells, Histone Deacetylases, Humans, Hydroxamic Acids, Repressor Proteins, Structure-Activity Relationship, Triazoles, Drug Design, Molecular Structure, Cell Line, Tumor, Cell Proliferation, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.